Chandra Bhagat Pharma Past Earnings Performance
Past criteria checks 4/6
Chandra Bhagat Pharma has been growing earnings at an average annual rate of 28.4%, while the Healthcare industry saw earnings growing at 29.7% annually. Revenues have been growing at an average rate of 26.3% per year. Chandra Bhagat Pharma's return on equity is 4.2%, and it has net margins of 0.6%.
Key information
28.4%
Earnings growth rate
14.7%
EPS growth rate
Healthcare Industry Growth | 29.4% |
Revenue growth rate | 26.3% |
Return on equity | 4.2% |
Net Margin | 0.6% |
Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Chandra Bhagat Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 1,948 | 12 | 21 | 0 |
30 Jun 23 | 1,573 | 10 | 20 | 0 |
31 Mar 23 | 1,198 | 9 | 18 | 0 |
31 Dec 22 | 1,075 | 8 | 20 | 0 |
30 Sep 22 | 953 | 7 | 22 | 0 |
30 Jun 22 | 948 | 8 | 22 | 0 |
31 Mar 22 | 942 | 8 | 21 | 0 |
31 Dec 21 | 928 | 7 | 24 | 0 |
30 Sep 21 | 915 | 6 | 26 | 0 |
30 Jun 21 | 811 | 4 | 26 | 0 |
31 Mar 21 | 707 | 2 | 25 | 0 |
31 Dec 20 | 823 | 3 | 28 | 0 |
30 Sep 20 | 940 | 3 | 24 | 0 |
30 Jun 20 | 940 | 3 | 24 | 0 |
31 Mar 20 | 940 | 3 | 31 | 0 |
31 Mar 19 | 1,063 | 7 | 57 | 0 |
31 Mar 18 | 971 | 10 | 64 | 0 |
31 Mar 17 | 899 | 7 | 67 | 0 |
Quality Earnings: 542934 has high quality earnings.
Growing Profit Margin: 542934's current net profit margins (0.6%) are lower than last year (0.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 542934's earnings have grown significantly by 28.4% per year over the past 5 years.
Accelerating Growth: 542934's earnings growth over the past year (59.8%) exceeds its 5-year average (28.4% per year).
Earnings vs Industry: 542934 earnings growth over the past year (59.8%) exceeded the Healthcare industry 28%.
Return on Equity
High ROE: 542934's Return on Equity (4.2%) is considered low.